🇬🇧 GSK.L — GSK plc

Healthcare Mantener
← Volver

Precio actual

1.837,50 GBp

Máx. histórico

2.746,59

1546 días

Split 4:5 del 19/07/2022

Caída desde máximo

-33,10%

Rango 52 semanas

1.445,00 – 2.282,00

Variación hoy

-0,49%

Cierre anterior

1.846,50

Rango de hoy

1.825,50 – 1.849,50

Volumen hoy

3.667.724

Información
Nombre completo
GSK plc
Divisa
GBp
Mercado
LSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
66.841
PER ⓘ
15,57 (puede no estar actualizado)
Dividend yield
3,68% (puede no estar actualizado)
Precio objetivo analistas
2.168,80 GBp (puede no estar actualizado)
Primera cotización
01/07/1988
Precio actualizado
hace 16 horas
Sobre la empresa

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and inhaled medicines for HIV, respiratory eosinophildriven diseases, lupus and lupus nephritis, ovarian cancer, and endometrial cancer. It also provides vaccines for Shingles, Meningitis, RSV, Seasonal Influenza, Hepatitis, Diphtheria, Tetanus, Acellular Pertussis, Rotavirus, Pertussis, Polio, Haemophilus, Invasive Diseases, Pneumonia, Acute Otitis Media, Measles, Mumps, Rubella and Chickenpox, and Human Papilloma Virus. Additionally, the company offers general medicines for asthma, COPD, bacterial infection, benign prostatic hyperplasia, allergic rhinitis, and inflammatory skin conditions. It also focuses on the discovery, development, and commercialization of oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. It has a collaboration agreement with CureVac to develop mRNA vaccines for infectious diseases; and strategic research collaboration with Engitix Ltd. to identify and validate novel therapeutic targets driving liver fibrosis regression. The company has a strategic alliance with AN2 Therapeutics, Inc. for the development of new therapies for TB. GSK plc was formerly known as GlaxoSmithKline plc and changed its name to GSK plc in May 2022. The company was founded in 1715 and is headquartered in London, United Kingdom.

Dividendos repartidos Total últimos 12 meses: 68,0000 GBp · Yield: 3,70%
Fecha de pago Importe por participación
13/08/2026 17,0000 GBp
14/05/2026 17,0000 GBp
19/02/2026 18,0000 GBp
13/11/2025 16,0000 GBp
14/08/2025 16,0000 GBp
15/05/2025 16,0000 GBp
20/02/2025 16,0000 GBp
14/11/2024 15,0000 GBp
15/08/2024 15,0000 GBp
16/05/2024 15,0000 GBp
22/02/2024 16,0000 GBp
16/11/2023 14,0000 GBp
17/08/2023 14,0000 GBp
18/05/2023 14,0000 GBp
23/02/2023 13,7500 GBp
Splits Registrados en el histórico de precios
Fecha Ratio
19/07/2022 4:5
28/10/1991 2:1
24/11/1989 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
04/12/2009 1.291,94 1.323,16 1.291,43 1.321,15 +2,22% 2,46% 10.381.284
03/12/2009 1.287,40 1.296,47 1.276,32 1.292,44 +0,08% 1,56% 7.692.456
02/12/2009 1.284,38 1.297,48 1.280,35 1.291,43 +0,16% 1,33% 5.239.757
01/12/2009 1.269,77 1.289,42 1.267,26 1.289,42 +1,83% 1,75% 6.937.315
30/11/2009 1.285,39 1.287,91 1.266,25 1.266,25 -1,72% 1,68% 11.309.226
27/11/2009 1.269,77 1.295,46 1.258,69 1.288,41 +0,55% 2,90% 5.744.472
26/11/2009 1.292,44 1.298,99 1.280,35 1.281,36 -1,36% 1,44% 6.902.840
25/11/2009 1.282,87 1.302,51 1.280,86 1.298,99 +1,42% 1,69% 25.094.762
24/11/2009 1.275,31 1.291,43 1.269,77 1.280,86 -0,47% 1,70% 10.701.619
23/11/2009 1.271,29 1.295,46 1.268,26 1.286,90 +1,91% 2,14% 8.783.487
20/11/2009 1.252,15 1.266,25 1.246,61 1.262,72 +1,05% 1,57% 12.108.143
19/11/2009 1.259,20 1.261,21 1.245,60 1.249,63 -0,52% 1,24% 17.876.665
18/11/2009 1.254,16 1.262,22 1.252,65 1.256,18 -0,04% 0,76% 6.896.687
17/11/2009 1.256,18 1.257,18 1.250,13 1.256,68 -0,28% 0,56% 5.449.952
16/11/2009 1.252,15 1.263,23 1.247,11 1.260,20 +0,00% 1,29% 4.930.666
13/11/2009 1.264,23 1.269,77 1.254,66 1.260,20 -0,64% 1,20% 5.743.607
12/11/2009 1.254,16 1.279,85 1.253,66 1.268,26 +1,04% 2,09% 10.377.032
11/11/2009 1.244,59 1.260,71 1.239,05 1.255,17 +0,77% 1,74% 7.503.153
10/11/2009 1.246,61 1.251,14 1.242,07 1.245,60 +0,20% 0,73% 5.248.440
09/11/2009 1.234,52 1.247,61 1.220,92 1.243,08 +1,23% 2,16% 5.475.255
06/11/2009 1.230,99 1.231,49 1.209,33 1.227,97 -0,08% 1,80% 6.269.724
05/11/2009 1.220,92 1.233,51 1.212,86 1.228,98 -0,12% 1,69% 8.679.939
04/11/2009 1.234,01 1.234,52 1.216,89 1.230,49 -0,57% 1,43% 7.895.221
03/11/2009 1.240,06 1.243,08 1.219,41 1.237,54 -1,48% 1,91% 10.615.585
02/11/2009 1.264,23 1.274,31 1.236,53 1.256,18 -0,24% 2,99% 8.558.547
30/10/2009 1.260,20 1.273,80 1.242,58 1.259,20 -0,32% 2,48% 11.592.747
29/10/2009 1.259,70 1.268,26 1.239,05 1.263,23 +0,24% 2,32% 9.774.937
28/10/2009 1.260,71 1.276,32 1.233,01 1.260,20 -0,44% 3,44% 12.003.530
27/10/2009 1.240,56 1.278,34 1.227,97 1.265,75 +2,15% 4,06% 11.117.406
26/10/2009 1.249,12 1.258,19 1.235,52 1.239,05 -0,53% 1,81% 6.787.460